Theracryf Plc (LON:TCF)
0.25p+7.30%
Spriggl Score: Weak— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“First safety test passed, second pending; binary outcome for this cash-burning drug developer.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Theracryf Plc
Theracryf Plc, a clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders. The company develops orexin-1 antagonist for the treatment of binge eating disorder and anxiety; and atypical dopamine transporter inhibi…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £5.1M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Theracryf Plc and 1,600+ UK and US stocks.
Start free